Attached is an April 5, 2023 letter to the Biden Administration requesting a reversal of the United States’ position on restricting public access to the drafts of the negotiating texts of the WHO pandemic accord. The letter is signed by… Continue Reading
In February 2023, Knowledge Ecology International (KEI) circulated two memos providing analysis on the WHO INB. pandemic CA+ zero draft text. The first memo provides KEI’s take on Article 10 of the zero draft. The memo elaborates on thee provisions… Continue Reading
NOTE: KEI also submitted a 16-page in depth written submission to this investigation on March 20, 2023. The US International Trade Commission (ITC) will hold a hearing on March 29-30, 2023 on COVID–19 Diagnostics and Therapeutics: Supply, Demand, and TRIPS… Continue Reading
On March 23, 2023, three prostate cancer patients, Robert Sachs, Clare Love and Eric Sawyer, filed an administrative appeal of the NIH decision to reject petition that HHS use Federal rights in patents on Xtandi to address pricing discrimination against… Continue Reading
NIH-rejection-Xtandi-marchin-21march2023 This is an appalling decision. The worst is this quote: “practical application is evidenced by the “manufacture, practice, and operation” of the invention and the invention’s “availability to and use by the public….” This is what 35 USC 201(f)… Continue Reading
ITC-KEI-COVID-TRIPS-30March2023
On March 20, 2023, Knowledge Ecology International (KEI) submitted comments to the National Institutes of Health (NIH) regarding the “Prospective Grant of an Exclusive Patent License: The Development of a CD276 Antibody-Drug Conjugate (ADC) for the Treatment of Solid Tumors”… Continue Reading
On Friday, 17 March 2023, Knowledge Ecology International (KEI) delivered the following intervention on recorded and streamed music at the 43rd session of WIPO’s Standing Committee on Copyright and Related Rights (SCCR). KEI will direct its comments to the topic… Continue Reading
On Thursday, 16 March 2023, Knowledge Ecology International (KEI) delivered the following statement on the future work of WIPO’s Standing Committee on Copyright and Related Rights (SCCR). KEI encourages the SCCR to include in its future work, the topics of… Continue Reading
I’m in a two day meeting in Geneva on new approaches to affordable monoclonal antibodies (mAbs), and it made me think of a provision found in some bills that have been proposed or introduced in the U.S. Congress to force… Continue Reading